The potential mechanism may be associated with inhibiting the activation of PI3K/AKT signal pathway, which may serve as a potential treatment for HCC therapy, providing a new direction for the clinical management of HCC. This evidence concerns the gene AKT1 and hepatocellular carcinoma.